Utvidet returrett til 31. januar 2024

Innovations for Next-Generation Antibody-Drug Conjugates

Om Innovations for Next-Generation Antibody-Drug Conjugates

While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

Vis mer
  • Språk:
  • Engelsk
  • ISBN:
  • 9783319781532
  • Bindende:
  • Hardback
  • Sider:
  • 357
  • Utgitt:
  • 11. juni 2018
  • Utgave:
  • 12018
  • Dimensjoner:
  • 155x235x0 mm.
  • Vekt:
  • 717 g.
  • BLACK NOVEMBER
  Gratis frakt
Leveringstid: 2-4 uker
Forventet levering: 27. november 2024

Beskrivelse av Innovations for Next-Generation Antibody-Drug Conjugates

While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.

Brukervurderinger av Innovations for Next-Generation Antibody-Drug Conjugates



Finn lignende bøker
Boken Innovations for Next-Generation Antibody-Drug Conjugates finnes i følgende kategorier:

Gjør som tusenvis av andre bokelskere

Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.